제품 정보로 건너뛰기
1 1

Cloud-clone

SKU(재고 관리 코드):PAA979Po01

Polyclonal Antibody to Cyclophilin A (CYPA)

Polyclonal Antibody to Cyclophilin A (CYPA)

UOM
Concentration
Organism species

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Product No.

PAA979Po01

Organism Species

Sus scrofa; Porcine (Pig).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

RPA979Po01-Recombinant Cyclophilin A (CYPA)

Buffer Formulation

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Homo sapiens (Human), Mus musculus (Mouse), Rattus norvegicus (Rat)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against CYPA. It has been selected for its ability to recognize CYPA in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

Atherosclerosis

EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation PubMed: 19758589

Biomarkers

Cyclophilin-A: a novel biomarker for untreated male essential hypertension Pubmed: 24164594

Cardiovascular Diabetology

Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease Pubmed:24502618

International Journal of Biological Sciences

Decrease in Plasma Cyclophilin A Concentration at 1 Month after Myocardial Infarction Predicts Better Left Ventricular Performance and Synchronicity at 6 Months: A Pilot Study in Patients with ST Elevation Myocardial Infarction Pubmed:25552928

Medicine

Cyclophilin A in Ruptured Intracranial Aneurysm PubMed: 26426668

Mol Cell Biochem

PPIA rs6850: A> G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease PubMed: 26702934

Medicine (Baltimore)

Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus PubMed: 26496315

International Journal of Cardiology

Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesisvia the SDF-1/CXCR4 axis. Pubmed:27057951

Clinica Chimica Acta

Novel findings of secreted cyclophilin A in diabetic nephropathy and its association with renal protection of dipeptidyl peptidase 4 inhibitor pubmed:27823952

Cardiovascular Diabetology

Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus. pubmed:27809851

Clinical Science

Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity Pubmed:29382697

Journal of Molecular Histology

Cyclophilin a increases CD68 cell infiltration in rat experimental periodontitis Pubmed:29318411

Free Radical Research

Cyclophilin A and CD147 associate with progression of diabetic nephropathy Pubmed: 30572748

The Kaohsiung Journal of Medical Sciences

Association of cyclophilin A level and pulse pressure in predicting recurrence of cerebral infarction Pubmed: 31670477

Cells.

Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients Pubmed: 31936351

JAMA Neurology

APPENDIX A: Relationship between cyclophilin A levels and matrix metalloproteinase-9 activity in cerebrospinal fluid of cognitively normal apolipoprotein E4 carriers … Pubmed: 24030206

Menoufia Medical Journal

Urinary podocalyxin and cyclophilin A: markers for early detection of type 2 diabetic nephropathy

Toxins

Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy 34437430

Cell Death & Disease

Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death Pubmed:35732625


Catalog No.

Related products for research use of Sus scrofa; Porcine (Pig) Organism species

Applications (RESEARCH USE ONLY!)

RPA979Po01

Recombinant Cyclophilin A (CYPA)

Positive Control; Immunogen; SDS-PAGE; WB.

PAA979Po01

Polyclonal Antibody to Cyclophilin A (CYPA)

WB; IHC; ICC; IP.

LAA979Po71

Biotin-Linked Polyclonal Antibody to Cyclophilin A (CYPA)

WB; IHC; ICC.

 

전체 세부 정보 보기